Abstract
A control series of 105 patients in hospital with non-malignant diseases was used in a limited clinical assessment of the MOD-MEM test. Twenty-seven positive results could be explained on the basis of destruction of nervous parenchyma, tissue necrosis, tuberculosis, malignant disease, etc. The remaining 13 unexplained positives showed a sex and age distribution in agreement with that predicted from cancer registration statistics if the MOD-MEM test detects cancer about 16 years before the clinical appearance of the disease.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caspary E. A., Feinmann E. L., Field E. J. Lymphocyte sensitization in asthma with special reference to nature and identity of intrinsic form. Br Med J. 1973 Jan 6;1(5844):15–16. doi: 10.1136/bmj.1.5844.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FIELD E. J., CASPARY E. A., BALL E. J. Some biological properties of a highly active encephalitogenic factor isolated from human brain. Lancet. 1963 Jul 6;2(7297):11–13. doi: 10.1016/s0140-6736(63)92533-9. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A., Shepherd R. T. Immunodiagnosis of cancer. Br Med J. 1972 Sep 9;3(5827):641–642. doi: 10.1136/bmj.3.5827.641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDermott J. R., Caspary E. A., Dickinson J. P. Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography. Clin Exp Immunol. 1974 May;17(1):103–111. [PMC free article] [PubMed] [Google Scholar]
- Meyer-Rienecker H., Jenssen H. L., Köhler H., Günther J., Gundlach H. J. Zur Anwendung und Bedeutung des Makrophagen-Elektrophorese-Mobilitäts-(MEM)-Testes bei neurologischen Erkrankungen. Klin Wochenschr. 1974 May 15;52(6):288–292. doi: 10.1007/BF01468460. [DOI] [PubMed] [Google Scholar]
- Preece A. W., Light P. A. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors. Clin Exp Immunol. 1974 Dec;18(4):543–552. [PMC free article] [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation. Lancet. 1972 Sep 23;2(7778):627–629. doi: 10.1016/s0140-6736(72)93018-8. [DOI] [PubMed] [Google Scholar]
- Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer Suppl. 1973 Aug;1:229–236. [PMC free article] [PubMed] [Google Scholar]
- Shenton B. K., Hughes D., Field E. J. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection. Br J Cancer Suppl. 1973 Aug;1:215–218. [PMC free article] [PubMed] [Google Scholar]
- Tognella S., Mantovani G., Floris C., Cengiarotti L., Del Giacco G. S., Grifoni V. Test citoferometrico per l'evidenziazione di linfociti sensibilizzati ad antigeni neoplastici (MEM test) Tumori. 1974 May-Jun;60(3):203–210. doi: 10.1177/030089167406000305. [DOI] [PubMed] [Google Scholar]